IBT resolves on a rights issue | MarketScreener

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND,... | May 16, 2023

Related Keywords

Switzerland ,Japan ,Sweden ,South Korea ,Hong Kong ,Belarus ,United Kingdom ,New Zealand ,Singapore ,Russia ,United States ,Canada ,Australia ,South Africa ,Stockholm ,American ,Swedish ,America ,David Dangoor ,Sebastian Jahreskog ,Commission Delegated Directive ,Swedish Financial Supervisory Authority ,Fourth Ap Fund ,European Union Withdrawal ,Neither The Company ,Carnegie Investment Bank ,Swedish Securities Council Sw ,Financial Services ,Infant Bacterial Therapeutics ,Rights Issue ,Extraordinary General Meeting ,Rothschild Investments ,Nasdaq Stockholm ,Swedish Securities Council ,Sole Global Coordinator ,Sole Bookrunner ,Advokatfirman Vinge ,United States Securities Act ,Securities Act ,European Economic Area ,Prospectus Regulation ,European Union ,Markets Act ,Financial Promotion ,Investment Bank ,Governance Requirements ,Business Sourcebook ,Kingdom Target Market ,Market Assessment ,Target Market Assessment ,Infant Bacterial Therapeutics Ab Publ Stock Exchange ,News ,Information ,Press Release ,Lot ,Or ,Distribution ,Dr ,N ,Whole ,Irectly ,Into ,The ,United ,States ,F ,Few ,Ong Ibtb Se0008015259 ,